Pancreas Powder

4 trials 2 recruiting AGastroenterology

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

2 Completed trials

3 Sponsors

6 Countries

Phase III

Phase IV

Phase I (Other)

Phase III: 1 Phase IV: 2 Phase I (Other): 1

Indications tested

Cystic fibrosis gastrointestinal disease 1

Sponsors using this IMP

MEDA Pharma GmbH & Co. KG 2 BGP Products Operations GmbH 1 Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela 1

All trials

4 total

Role of Pancreatic Enzyme Replacement Therapy (PERT) (Creon®) for Pancreatic Exocrine Insufficiency (PEI) after Pancreatic Surgery Recruiting

2024-512798-29-00 Phase III 3 countries MEDA Pharma GmbH & Co. KG
Open label randomized, multicentre, controlled trial of pancreatic enzyme replacement therapy (PERT) for pancreatic exocrine insufficiency (… Recruiting

2023-507367-18-00 Phase IV 3 countries Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela
Role of Pancreatic Enzyme Replacement Therapy (PERT) (Creon®) in Pancreatic Exocrine Insufficiency (PEI) due to gastrectomy. Ended

2023-507837-18-00 Phase IV 3 countries BGP Products Operations GmbH
Open-label single-arm, multicenter clinical trial to evaluate patient acceptability of a new CREON formulation of Pancreas Powder gastro-res… Ended

2023-503256-27-00 Phase I (Other) 1 country MEDA Pharma GmbH & Co. KG

Showing 1–4 of 4 trials

← All drugs A–Z